有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Rosiglitazone maleate;SB-206846((-)-enantiomer;free base);SB-210232((+)-enantiomer;free base);BRL-49653C;Venvia;Nyracta;Avandia
Chemical Name (±)-5-[4-[2-[N-Methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleate
CAS 155141-29-0
Related CAS 122320-73-4 (free base)
Formula C22H23N3O7S
Structure
Formula Weight 473.50851
Stage 上市-1999
Company GlaxoSmithKline (Originator), Bristol-Myers Squibb (Licensee), Asahi Kasei (Distributor)
Activity/Mechanism Alzheimers Dementia, Treatment of , Antidiabetic Drugs, Antipsoriatics, Cognition Disorders, Treatment of, DERMATOLOGIC DRUGS, ENDOCRINE DRUGS, GASTROINTESTINAL DRUGS, Inflammatory Bowel Disease, Agents for, NEUROLOGIC DRUGS, Type 2 Diabetes Mellitus, Agents for, Insulin Sensitizers, PPARgamma Agonists, Thiazolidinediones (Glitazones)
Syn. Route 3
Route 1
the reaction of 2-chloropyridine (i) with 2-(methyl-amino)ethanol (ii) by heating at 150 c gives 2-[n-methyl-n-(2-pyridyl)amino]ethanol (iii), which is condensed with 4-fluorobenzaldehyde (iv) by means of nah in dmf, yielding 4-[2-[n-methyl-n-(2-pyridyl)amino]-ethoxy]benzaldehyde (v) (1-3). the reaction of (v) with thiazolidine-2,4-dione (vi) by means of piperidinium acetate in refluxing toluene affords 5-[4-[2-[n-methyl-n-(2-pyridyl)- amino]ethoxy]benzylidene]thiazolidine-2,4-dione (vii). finally, this compound is reduced with h2 over pd/c (1), mg in methanol (2,3) or biocatalytically by incubation with whole cells of the yeast rhodotorula rubra cbs 6469 at ph 7.5-8.0 (4-6). under acidic conditions, ph 3.0-5.0, this microbial biotransformation is enantioselective, giving the (+)-(r)-enantiomer of rosiglitazone.
List of intermediates No.
6-bromo-2-methylquinoline (vi)
methyl (1r,2s,3r)-3-acetyl-4-oxo-2-(3-phenylpropyl)cyclopentanecarboxylate (iv)
tert-butyl 4-[2-[4-(3,10-dibromo-8-chloro-5,6-dihydro-11h-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxylate (ii)
ethyl (3ar,5r,7r,7as)-5,7-dihydroxy-2,2-dimethylhexahydro-1,3-benzodioxole-5-carboxylate (i)
ethyl (3ar,7r,7ar)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate (iii)
ethyl (3r,4r,5r)-3-(1-ethylpropoxy)-4-hydroxy-5-[(methylsulfonyl)oxy]-1-cyclohexene-1-carboxylate (v)
ethyl (3r,4s,5r)-5-azido-3-(1-ethylpropoxy)-4-hydroxy-1-cyclohexene-1-carboxylate (vii)
Reference 1:
    jones, j.j.; verrall, m.s.; heath, c.m.; imrie, r.c.; rees, m.j.; robins, k.g.; whole cell biotransformation of 5-(4-(2-(2-pyridyl)methylamino)ethoxy)benzylidenethiazolidine-2,4-dione to its benzyl derivative using a yeast reductase. j chem tech biotech 1997, 68, 324-30.
Reference 2:
    cantello, b.c.c.; haigh, d.; eggleston, d.s.; jennings, k.r.; heath, c.m.; sime, j.t.; haltiwanger, r.c.; woroniecki, s.r.; hindley, r.m.; facile biocatalytic reduction of the carbon-carbon double bond of 5-benzylidenethiazolidine-2,4-diones. synthesis of (?-5-(4-(2-[methyl(2-pyridyl)amino]ethoxy)benzyl)-thiazolidine-2,4-dione (brl 49653), its (r)-(?-enantiomer and analogues. j chem soc - perkins trans i 1994, 22, 22, 3319-24.
Reference 3:
    thurlby, p.l.; lister, c.a.; duff, p.t.; hindley, r.m.; cottam, g.p.; haigh, d.; smith, s.a.; cantello, bb.c.c.; cawthorne, m.a.; [[*-(heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. j med chem 1994, 37, 23, 3977-85.
Reference 4:
    sorbera, l.a.; rabasseda, x.; leeson,p.a.; rosiglitazone maleate. drugs fut 1998, 23, 9, 977.
Reference 5:
    hindley, r.m. (smithkline beecham plc); substd. thiazolidine-dione derivs. au 8821738; ep 0306228; ep 0842925; jp 1989131169; jp 1997183726; jp 1997183771; jp 1997183772; jp 1998194970; jp 1998194971; us 5002953; us 5194443; us 5232925; us 5646169 .
Reference 6:
    hindley, r.m.; woroniecki, s.r. (smithkline beecham plc); process for the preparation of pharmaceutically active thiazolidine or oxazolidine cpds. by a yeast reductase. wo 9310254 .
Reference 7:
    vyas, s.k. (torrent pharmaceuticals ltd.); process for the preparation of rosiglitazone maleate. us 2002115866; us 6515132; wo 0251823 .
Reference 8:
    smith, s.a.; thurlby, p.l.; cantello, b.c.c.; haigh, d.; cawthorne, m.a.; hindley, r.m.; the synthesis of brl 49653 - a novel and potent antihyperglycaemic agent. bioorg med chem lett 1994, 4, 10, 1181-4.

Route 2
the bromination of rosiglitazone (i) with nbs in hot acetic acid gives the dibromo compound (ii), which is the hydrogenated with tritium over pd/baso4 in dmf/tea to yield the target labeled compound.
List of intermediates No.
Reference 1:
    kirefu, t.; landwater, s.w.; latter, a.j.; lawrie, k.w.m.; morecombe, d.j.; willcocks, k.; rosiglitazone maleate (brl 49653-c); the preparation of [14c] and [3h] isotopomers. j label compd radiopharm 2001, 44, 5, 329.

Route 3
the reaction of 4-fluoroiodobenzene (i) with 14c-kcn and cui in refluxing dmf gives 4-fluorobenzonitrile (ii), which is reduced with hco2h and rani in dmf to yield 4-fluorobenzaldehyde (iii). the condensation of (iii) with the substituted ethanolamine (iv) by means of tbu-ok in dmf affords 4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzaldehyde (v), which is condensed with thiazolidine-2,4-dione (vi) by means of piperidine acetate in refluxing toluene to provide the benzylidene-thiazolidinedione (vii). finally this compound is hydrogenated with h2 over pd/c in dmf to furnish the target labeled compound.
List of intermediates No.
6-bromo-2-methylquinoline (vi)
ethyl (3ar,7r,7ar)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate (iv)
Reference 1:
    kirefu, t.; landwater, s.w.; latter, a.j.; lawrie, k.w.m.; morecombe, d.j.; willcocks, k.; rosiglitazone maleate (brl 49653-c); the preparation of [14c] and [3h] isotopomers. j label compd radiopharm 2001, 44, 5, 329.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名马来酸罗格列酮;英文名Rosiglitazone maleate;SB-206846((-)-enantiomer;free base);SB-210232((+)-enantiomer;free base);BRL-49653C;Venvia;Nyracta;Avandia;CAS[155141-29-0]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
正丁醇价格持续走跌
华北地区BDO市场观望整理
山东地区甲醛行情下跌
华东地区BDO市场疲态难改
河北地区甲醛价格下跌
醋酐市场继续下行
华南地区BDO市场商谈偏弱
华北地区BDO市场行情僵持
华南地区BDO市场行情清淡
华东地区BDO市场行情暂稳
浙江地区二氯甲烷价格暂稳
华北地区丁二烯市场价格盘整
山东地区二氯甲烷市场价格暂稳
华东地区甲醛价格持稳
华东地区丁二烯市场价格盘整
浙江地区二氯甲烷价格暂稳
山东地区木薯乙醇市场变动不大
山东地区辛醇市场气氛清淡
山东地区三氯甲烷价格
山东地区二氯甲烷市场价格暂稳
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明